Cargando…
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
Metabolic-dysfunction-associated fatty liver disease (MAFLD) is the recent nomenclature designation that associates the condition of non-alcoholic fatty liver disease (NAFLD) with metabolic dysfunction. Its diagnosis has been debated in the recent period and is generally associated with a diagnosis...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054528/ https://www.ncbi.nlm.nih.gov/pubmed/36984595 http://dx.doi.org/10.3390/medicina59030594 |
_version_ | 1785015692816285696 |
---|---|
author | Abenavoli, Ludovico Scarlata, Giuseppe Guido Maria Scarpellini, Emidio Boccuto, Luigi Spagnuolo, Rocco Tilocca, Bruno Roncada, Paola Luzza, Francesco |
author_facet | Abenavoli, Ludovico Scarlata, Giuseppe Guido Maria Scarpellini, Emidio Boccuto, Luigi Spagnuolo, Rocco Tilocca, Bruno Roncada, Paola Luzza, Francesco |
author_sort | Abenavoli, Ludovico |
collection | PubMed |
description | Metabolic-dysfunction-associated fatty liver disease (MAFLD) is the recent nomenclature designation that associates the condition of non-alcoholic fatty liver disease (NAFLD) with metabolic dysfunction. Its diagnosis has been debated in the recent period and is generally associated with a diagnosis of steatosis and at least one pathologic condition among overweight/obesity, type 2 diabetes mellitus, and metabolic dysregulation. Its pathogenesis is defined by a “multiple-hit” model and is associated with alteration or dysbiosis of the gut microbiota. The pathogenic role of dysbiosis of the gut microbiota has been investigated in many diseases, including obesity, type 2 diabetes mellitus, and NAFLD. However, only a few works correlate it with MAFLD, although common pathogenetic links to these diseases are suspected. This review underlines the most recurrent changes in the gut microbiota of patients with MAFLD, while also evidencing possible pathogenetic links. |
format | Online Article Text |
id | pubmed-10054528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100545282023-03-30 Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome Abenavoli, Ludovico Scarlata, Giuseppe Guido Maria Scarpellini, Emidio Boccuto, Luigi Spagnuolo, Rocco Tilocca, Bruno Roncada, Paola Luzza, Francesco Medicina (Kaunas) Review Metabolic-dysfunction-associated fatty liver disease (MAFLD) is the recent nomenclature designation that associates the condition of non-alcoholic fatty liver disease (NAFLD) with metabolic dysfunction. Its diagnosis has been debated in the recent period and is generally associated with a diagnosis of steatosis and at least one pathologic condition among overweight/obesity, type 2 diabetes mellitus, and metabolic dysregulation. Its pathogenesis is defined by a “multiple-hit” model and is associated with alteration or dysbiosis of the gut microbiota. The pathogenic role of dysbiosis of the gut microbiota has been investigated in many diseases, including obesity, type 2 diabetes mellitus, and NAFLD. However, only a few works correlate it with MAFLD, although common pathogenetic links to these diseases are suspected. This review underlines the most recurrent changes in the gut microbiota of patients with MAFLD, while also evidencing possible pathogenetic links. MDPI 2023-03-17 /pmc/articles/PMC10054528/ /pubmed/36984595 http://dx.doi.org/10.3390/medicina59030594 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Abenavoli, Ludovico Scarlata, Giuseppe Guido Maria Scarpellini, Emidio Boccuto, Luigi Spagnuolo, Rocco Tilocca, Bruno Roncada, Paola Luzza, Francesco Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome |
title | Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome |
title_full | Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome |
title_fullStr | Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome |
title_full_unstemmed | Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome |
title_short | Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome |
title_sort | metabolic-dysfunction-associated fatty liver disease and gut microbiota: from fatty liver to dysmetabolic syndrome |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054528/ https://www.ncbi.nlm.nih.gov/pubmed/36984595 http://dx.doi.org/10.3390/medicina59030594 |
work_keys_str_mv | AT abenavoliludovico metabolicdysfunctionassociatedfattyliverdiseaseandgutmicrobiotafromfattylivertodysmetabolicsyndrome AT scarlatagiuseppeguidomaria metabolicdysfunctionassociatedfattyliverdiseaseandgutmicrobiotafromfattylivertodysmetabolicsyndrome AT scarpelliniemidio metabolicdysfunctionassociatedfattyliverdiseaseandgutmicrobiotafromfattylivertodysmetabolicsyndrome AT boccutoluigi metabolicdysfunctionassociatedfattyliverdiseaseandgutmicrobiotafromfattylivertodysmetabolicsyndrome AT spagnuolorocco metabolicdysfunctionassociatedfattyliverdiseaseandgutmicrobiotafromfattylivertodysmetabolicsyndrome AT tiloccabruno metabolicdysfunctionassociatedfattyliverdiseaseandgutmicrobiotafromfattylivertodysmetabolicsyndrome AT roncadapaola metabolicdysfunctionassociatedfattyliverdiseaseandgutmicrobiotafromfattylivertodysmetabolicsyndrome AT luzzafrancesco metabolicdysfunctionassociatedfattyliverdiseaseandgutmicrobiotafromfattylivertodysmetabolicsyndrome |